Results 61 to 70 of about 5,560 (153)

Analyzing adverse event signals of aprepitant using FAERS database data in real-world settings: Broadening the adverse event spectrum of aprepitant and its clinical implications. [PDF]

Medicine (Baltimore)
Chen F, Cai D, Wen H, Zhang L.
europepmc   +1 more source

Comparison of aprepitant, dexamethasone, and ondansetron with dexamethasone and ondansetron for prevention of postoperative nausea and vomiting in high-risk patients undergoing laparoscopic surgeries: a randomized controlled trial in India. [PDF]

J Minim Invasive Surg
Bala S, Meshram TM, Bhatia P, Rathod D, Kaur M, Kumari K.   +5 more
europepmc   +1 more source

Exploring Potential Drug-Drug Interactions: A Cross-Sectional Study of 1 Million e-Prescriptions Across Medical Specialties in Shiraz, Iran (2021-2024). [PDF]

Iran J Med Sci
Porbaha P, Hasannejad M, Ahvar N, Shafiekhani M, Abolpour N, Sharifi M.   +5 more
europepmc   +1 more source

Aprepitant alleviates acute lung injury in a rat model of hepatic ischemia-reperfusion via NLRP3/IL-1β signaling pathway. [PDF]

Sci Rep
Abdelzaher WY, Kelleni MT, Adly MN, Attya ME, Fawzy MA, Ibrahim MA.   +5 more
europepmc   +1 more source

The combined anti-tumor effects of 5-fluorouracil and neurokinin receptor inhibitor, aprepitant, against colorectal cancer: In vitro and in vivo study

Medical Oncology
Abbas Alalikhan, Safieh Ebrahimi, Ali Aliee, Farshad Mirzavi, S. Hashemy   +4 more
semanticscholar   +1 more source

Three are better than two: redefining prophylaxis for postoperative nausea and vomiting. [PDF]

J Minim Invasive Surg
Kang H.
europepmc   +1 more source

Scratching the surface: NK-1 inhibitors for chronic itch-Promise or placebo? [PDF]

J Eur Acad Dermatol Venereol
Yosipovitch G.
europepmc   +1 more source

Regulation of Aldosterone Secretion by Substance P and the Neurokinin Type 1 Receptor in Aldosterone-Producing Adenomas. [PDF]

J Am Heart Assoc
Lopez AG, Duparc C, Renouf S, D'Agostino M, De Sousa K, Amar L, Defortescu G, Manceau G, Sabourin JC, Fernandes-Rosa FL, Zennaro MC, Meatchi T, Nicolas G, Louiset E, Lefebvre H.   +14 more
europepmc   +1 more source

Exploring neurokinin-1 receptor antagonism for depression with structurally differentiated inhibitors. [PDF]

Exp Mol Med
Yoo H, Boo KJ, Nguyen LP, Hwang JI, Lee CS, Yang SH, Jeon SJ, Kim HR, Kim H.   +8 more
europepmc   +1 more source

Anti-Metastatic Effects of Aprepitant on Glioblastoma Cells: Targeting the Substance P/Neurokinin-1 Pathway. [PDF]

Cancer Med
Engür-Öztürk S, Kaya-Tilki E, Dikmen M.   +2 more
europepmc   +1 more source